Zydus Lifesciences Drug Patent Portfolio
Zydus Lifesciences owns 1 orange book drug protected by 1 US patent Given below is the list of Zydus Lifesciences's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10925871 | Pharmaceutical compositions of sitagliptin | 25 Feb, 2035 | Active |
Latest Legal Activities on Zydus Lifesciences's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Zydus Lifesciences.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 23 Feb, 2021 | US10925871 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 23 Feb, 2021 | US10925871 |
|
Email Notification
Critical
| 04 Feb, 2021 | US10925871 |
|
Issue Notification Mailed
Critical
| 03 Feb, 2021 | US10925871 |
| Dispatch to FDC | 25 Jan, 2021 | US10925871 |
| Dispatch to FDC | 22 Jan, 2021 | US10925871 |
|
Issue Fee Payment Verified
Critical
| 19 Jan, 2021 | US10925871 |
|
Application Is Considered Ready for Issue
Critical
| 19 Jan, 2021 | US10925871 |
|
Issue Fee Payment Received
Critical
| 19 Jan, 2021 | US10925871 |
|
Issue Fee Payment Verified
Critical
| 18 Jan, 2021 | US10925871 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 30 Dec, 2020 | US10925871 |
|
Email Notification
Critical
| 30 Dec, 2020 | US10925871 |
|
Response to Amendment under Rule 312
Critical
| 23 Dec, 2020 | US10925871 |
|
Amendment after Notice of Allowance (Rule 312)
Critical
| 21 Dec, 2020 | US10925871 |
| Mail PUB other miscellaneous communication to applicant | 19 Nov, 2020 | US10925871 |
Zydus Lifesciences's Family Patents
Zydus Lifesciences Drug List
Given below is the complete list of Zydus Lifesciences's drugs and the patents protecting them.
1. Zituvio
Zituvio is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10925871 | Pharmaceutical compositions of sitagliptin |
25 Feb, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zituvio's drug page